Acceleron

Acceleron Receives Two FDA Orphan Designations for ACE-536
Yahoo
Tue, 03/26/13 - 10:34 am
FDA
orphan drugs
ACE-536
Acceleron
beta-thalassemia
myelodysplastic syndromes
Acceleron inks $498M pact with Shire for lead muscle drug
Fierce Biotech
Thu, 09/9/10 - 12:30 pm
Shire
Acceleron
Alkermes, Acceleron in $10M licensing deal
Fierce Biotech
Fri, 12/4/09 - 09:55 am
Acceleron
licensing
Alkermes

Pages